Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 219-110-7 | CAS number: 2362-14-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Toxicological Summary
- Administrative data
- Workers - Hazard via inhalation route
- Workers - Hazard via dermal route
- Workers - Hazard for the eyes
- Additional information - workers
- General Population - Hazard via inhalation route
- General Population - Hazard via dermal route
- General Population - Hazard via oral route
- General Population - Hazard for the eyes
- Additional information - General Population
Administrative data
Workers - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 11.75 mg/m³
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 75
- Value:
- 1 000 mg/kg bw/day
- Modified dose descriptor starting point:
- NOAEC
- Value:
- 880 mg/m³
- Explanation for the modification of the dose descriptor starting point:
detailed explanation provided under Discussion
- AF for dose response relationship:
- 1
- AF for differences in duration of exposure:
- 6
- Justification:
- default value - subacute to chronic
- AF for other interspecies differences:
- 2.5
- Justification:
- default value - remaining differences
- AF for intraspecies differences:
- 5
- Justification:
- default value - workers
- AF for the quality of the whole database:
- 1
- AF for remaining uncertainties:
- 1
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Workers - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 3.33 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 300
- Modified dose descriptor starting point:
- NOAEL
- Value:
- 1 000 mg/kg bw/day
- Explanation for the modification of the dose descriptor starting point:
detailed explanation provided under Discussion
- AF for dose response relationship:
- 1
- AF for differences in duration of exposure:
- 6
- Justification:
- default value - subacute to chronic
- AF for interspecies differences (allometric scaling):
- 4
- Justification:
- default value - rat
- AF for other interspecies differences:
- 2.5
- Justification:
- default value - remaining differences
- AF for intraspecies differences:
- 5
- Justification:
- default value - workers
- AF for the quality of the whole database:
- 1
- AF for remaining uncertainties:
- 1
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
Workers - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- no hazard identified
Additional information - workers
Based on the available acute toxicity data for the oral and dermal routes of exposure, both reporting LD50s >2000 mg/kg bw, DMBPC is not expected to be an acute toxicant by these routes, and therefore, derivation of long-term DNELs will be sufficient to control potential risks associated with short-term exposures. Sufficient information is available from studies performed according to OECD Guidelines to conclude that DMBPC does not produce local toxicity effects (e.g., skin and eye irritation, skin sensitisation). Skin irritation/corrosion and eye irritation tests on rabbits performed according to GLP/OECD Guidelines 404 and 405, respectively, are available which conclude that DMBPC is considered not irritating to skin and eyes. In addition, a skin sensitisation test on guinea pigs performed according to GLP/OECD Guideline 406 reported that DMBPC is not sensitising. Therefore, derivation of DNELs for local effects is not necessary.
A Derived-Minimal-Effect-Level (DMEL) is derived for substances classified as a carcinogen and/or mutagen. Genotoxicity data for DMPBC are available: a negative in vitro reverse bacterial mutation assay (Ames), a positive chromosomal aberration assay with Chinese Hamster Ovary (CHO) cells and a negative mouse lymphoma forward mutation assay. In addition, an in vivo mouse bone marrow micronucleus assay is available which reported that DMBPC was negative for inducing micronuclei. All of these assays were performed according to GLP/OECD Guidelines and the overall weight of evidence demonstrates a lack of genotoxicity. No carcinogenicity data are available for DMBPC; however, given the negative in vitro and in vivo genotoxicity results for DMBPC and a lack of neoplasia/hyperplasia in a 28-day repeated dose study performed according to GLP/OECD 422, it is unlikely that DMBPC is carcinogenic. Therefore, derivation of a DMEL is not appropriate and only a DNEL will be generated to assess effects resulting from long-term exposure to DMBPC.
The key study for derivation of the DNELs is a combined repeated dose toxicity / reproductive toxicity screening assay performed according to GLP/OECD 422 in which 10 rats/sex/dose were administered DMBPC via gavage for 28 d (males) and approximately 56 d (females) at doses of 0, 50, 200 and 1000 mg/kg bw/d (nominal). In addition, five additional males per group from the control and 1000 mg/kg bw/d dose groups were designated as recovery animals and held without dosing for two weeks after the dosing period.
The NOAEL reported in the combined repeated dose toxicity was 200 mg/kg bw/d based on statistically significant reductions in body weight and body weight gain in the 1000 mg/kg bw/d dose group. However, consistent with CLP classification guidelines these changes are not considered toxicologically relevant as there were no additional signs of overt toxicity. Therefore, for purposes of derivation of DNELs, the NOAEL is considered to be 1000 mg/kg bw/day.
A DNEL for systemic effects for the worker population is normally derived for the dermal and inhalation routes of exposure. Therefore, route-to-route extrapolation from the oral toxicity study was utilized for derivation of the DNEL. For route-to-route extrapolation from an oral dose to an inhalation dose the starting point needs to be modified to correct for the breathing volume of the rat and respiratory volume under standard conditions (6.7 m3/person) versus under conditions of light activity for workers (10 m3/person). Based on ECHA’s recommendations, it is assumed that respiratory absorption is equivalent between the animals and humans. Therefore, the inhalation starting dose = oral NOAEL x 1/(0.38 m3/kg bw/d) x 6.7 m3/10 m3. In addition, potential toxicokinetic properties inferred from existing toxicology studies and the physical chemical properties determined moderate (50%) oral absorption and complete (100%) inhalation absorption. Therefore, the inhalation starting dose for the worker population = 1000 mg/kg bw/d x 1/(0.38 m3/kg bw/d) x 6.7 m3/10 m3 x (50/100) = 880 mg/m3.
For route-to-route extrapolation for the dermal route, the absorption differences between the animal and human need to be considered for both the dermal and oral routes. The potential toxicokinetic properties inferred from existing toxicology studies and physical chemical properties set a dermal absorption value of 25% for humans, in accordance with principle adopted by the EFSA guidance on estimating dermal absorption of pesticide active substances. Therefore, the starting dose for calculation of the systemic dermal DNEL is 1000 mg/kg bw/d x (50/25) = 2000 mg/kg bw/day.
The AF for interspecies variability includes an allometric scaling (AS) factor plus an additional factor of 2.5. In the case of the rat, the ECHA recommended AS factor is 4. So the interspecies AF is equal to 4 x 2.5 = 10. However, for the inhalation route an AS factor is not used. Therefore, for inhalation, only an interspecies factor of 2.5 is used. ECHA R.8 Guidance Document (ECHA, 2010) recommends an AF of 5 to account for intraspecies variability among workers.
The AF for extrapolation from a subacute (e. g., 28-d) toxicity study to a chronic is 6.
The total AF used to derive the systemic DNELlong-term for the inhalation route for the worker is 75 (2.5 x 5 x 6).
The total AF used to derive the systemic DNELlong-term for the dermal route for the worker is 300 (4 x 2.5 x 5 x 6)
Worker DNEL long-term systemic for the inhalation route = 880/75 = 11.7 mg DMBPC/m3.
Worker DNEL long-term systemic for the dermal route = 2000/300 = 6.7 mg DMBPC/kg bw/d
General Population - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
General Population - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
General Population - Hazard via oral route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
General Population - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- no hazard identified
Additional information - General Population
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.